Literature DB >> 7756609

Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization.

T Z Baram1, C E Ribak.   

Abstract

Status epilepticus (SE) produced by excitatory amino acids is a well established model in adult rodents. Limbic neuronal degeneration and synaptic reorganization observed after, for example, kainic acid-induced SE are considered relevant to human epilepsy. Kainic acid also produces severe seizures in infant rats, but neuronal injury and sprouting have not been demonstrated. The results of the present study show that corticotropin releasing hormone (CRH)-induced SE causes limbic neuronal death and reorganization in infant rats. In adults, CRH produced seizures at much higher doses, and no neuronal degeneration. As a modulator of the CNS stress response, CRH is activated in various 'stressful' circumstances. Its age-dependent ability to kill neurons represents a unique form of cell death potentially important in human medicine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756609      PMCID: PMC3477862          DOI: 10.1097/00001756-199501000-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  25 in total

Review 1.  Developmental differences in the neurobiology of epileptic brain damage.

Authors:  E F Sperber; P K Stanton; K Haas; R F Ackermann; S L Moshé
Journal:  Epilepsy Res Suppl       Date:  1992

2.  Bench to bedside: the glutamate connection.

Authors:  D W Choi
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

3.  Fine structure and possible origins of nerve fibers with corticotropin-releasing factor-like immunoreactivity in the rat central amygdaloid nucleus.

Authors:  K Uryu; T Okumura; T Shibasaki; M Sakanaka
Journal:  Brain Res       Date:  1992-04-10       Impact factor: 3.252

4.  Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing.

Authors:  H Monyer; P H Seeburg; W Wisden
Journal:  Neuron       Date:  1991-05       Impact factor: 17.173

5.  Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala.

Authors:  T Z Baram; E Hirsch; O C Snead; L Schultz
Journal:  Ann Neurol       Date:  1992-05       Impact factor: 10.422

6.  Use of excitatory amino acids to make axon-sparing lesions of hypothalamus.

Authors:  J V Nadler; D A Evenson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

8.  Progressive neuronal loss induced by kindling: a possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis.

Authors:  J E Cavazos; T P Sutula
Journal:  Brain Res       Date:  1990-09-10       Impact factor: 3.252

9.  Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats.

Authors:  J Cronin; F E Dudek
Journal:  Brain Res       Date:  1988-11-22       Impact factor: 3.252

10.  Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat.

Authors:  T Z Baram; L Schultz
Journal:  Brain Res Dev Brain Res       Date:  1991-07-16
View more
  27 in total

1.  Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus.

Authors:  Y Chen; K L Brunson; M B Müller; W Cariaga; T Z Baram
Journal:  J Comp Neurol       Date:  2000-05-08       Impact factor: 3.215

2.  Long-term neuroplasticity and functional consequences of single versus recurrent early-life seizures.

Authors:  Tallie Z Baram
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

3.  Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress.

Authors:  K L Brunson; M Eghbal-Ahmadi; R Bender; Y Chen; T Z Baram
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 4.  Hippocampal neuroplasticity induced by early-life stress: functional and molecular aspects.

Authors:  Kristina A Fenoglio; Kristen L Brunson; Tallie Z Baram
Journal:  Front Neuroendocrinol       Date:  2006-04-17       Impact factor: 8.606

Review 5.  Exposure to prenatal psychobiological stress exerts programming influences on the mother and her fetus.

Authors:  Curt A Sandman; Elysia P Davis; Claudia Buss; Laura M Glynn
Journal:  Neuroendocrinology       Date:  2011-04-15       Impact factor: 4.914

6.  Selective death of hippocampal CA3 pyramidal cells with mossy fiber afferents after CRH-induced status epilepticus in infant rats.

Authors:  C E Ribak; T Z Baram
Journal:  Brain Res Dev Brain Res       Date:  1996-02-26

7.  Cellular and molecular mechanisms of hippocampal activation by acute stress are age-dependent.

Authors:  Y Chen; K A Fenoglio; C M Dubé; D E Grigoriadis; T Z Baram
Journal:  Mol Psychiatry       Date:  2006-06-27       Impact factor: 15.992

8.  The developmental profile of the corticotropin releasing factor receptor (CRF2) in rat brain predicts distinct age-specific functions.

Authors:  M Eghbal-Ahmadi; C G Hatalski; T W Lovenberg; S Avishai-Eliner; D T Chalmers; T Z Baram
Journal:  Brain Res Dev Brain Res       Date:  1998-04-17

Review 9.  Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain.

Authors:  T Z Baram; C G Hatalski
Journal:  Trends Neurosci       Date:  1998-11       Impact factor: 13.837

10.  Mossy fiber plasticity and enhanced hippocampal excitability, without hippocampal cell loss or altered neurogenesis, in an animal model of prolonged febrile seizures.

Authors:  Roland A Bender; Celine Dubé; Rebeca Gonzalez-Vega; Erene W Mina; Tallie Z Baram
Journal:  Hippocampus       Date:  2003       Impact factor: 3.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.